Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer
- PMID: 37914742
- PMCID: PMC10620133
- DOI: 10.1038/s41523-023-00595-2
Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer
Abstract
Race and socioeconomic factors affect outcomes in breast cancer. We aimed to assess the effect of race and neighborhood socioeconomic status (SES) on overall survival and treatment patterns in patients with metastatic breast cancer (MBC). This is a retrospective cohort study involving patients (N = 1246) with distant breast cancer metastases diagnosed at UPMC Magee Women's Breast Cancer Clinic from 2000-2017. Overall survival and treatment patterns were compared between races (Blacks and whites) and SES groups (defined using Area Deprivation Index). Low SES, but not tumor characteristics, was associated with Black race (P < 0.001) in the study population. Low SES (Median [Interquartile Range, IQR] survival 2.3[2.2-2.5] years vs high SES 2.7[2.5-3.1] years, P = 0.01) and Black race (Median [IQR] survival 1.8[1.3-2.3] years, vs white 2.5[2.3-2.7] years P = 0.008) separately were associated with worse overall survival in patients with MBC. In the Cox Proportional Hazard model with SES, race, age, subtype, number of metastases, visceral metastasis, and year of diagnosis as covariates, low SES (Hazard ratio 1.19[1.04-1.35], P = 0.01), but not Black race (Hazard ratio 1.19[0.96-1.49], P = 0.12), independently predicted overall survival in MBC. Moreover, patients from low SES neighborhoods and Black race received fewer lines of chemotherapy than high SES and whites. In conclusion, low neighborhood SES is associated with worse outcomes in patients with MBC. Poor outcomes in Black patients with MBC, at least in part is driven by socioeconomic factors. Future studies should delineate the interplay between neighborhood SES, race, and their effects on tumor biology in MBC.
© 2023. The Author(s).
Conflict of interest statement
A.V.L.—Leadership/Stock or other ownership/Honoraria at Ocean Genomics, Consultant at L.E.K. Consulting, Research fundting at AstraZenica and PUMA. A.M.B.—Consultant at AstraZenica, Pfizer, Novartis, Lilly, Genentech/Roche, SeaGen, Daiichi Sankyo, Merck, Agendia, Sanofi, PUMA; Research support at Agendia, Astrazenica. The remaining authors (S.P.N., D.R., S.O., M.Q.R.) declare no competing interests.
Figures
Similar articles
-
Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.JAMA Netw Open. 2021 Dec 1;4(12):e2139593. doi: 10.1001/jamanetworkopen.2021.39593. JAMA Netw Open. 2021. PMID: 34919133 Free PMC article.
-
Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.Milbank Q. 2018 Dec;96(4):706-754. doi: 10.1111/1468-0009.12355. Milbank Q. 2018. PMID: 30537364 Free PMC article.
-
Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.Cancer J. 2014 Jul-Aug;20(4):237-45. doi: 10.1097/PPO.0000000000000058. Cancer J. 2014. PMID: 25098282
-
Socioeconomic factors and breast cancer in black and white Americans.Cancer Metastasis Rev. 2003 Mar;22(1):55-65. doi: 10.1023/a:1022212018158. Cancer Metastasis Rev. 2003. PMID: 12716037
-
Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies.Cancer. 2002 Nov 1;95(9):1988-99. doi: 10.1002/cncr.10830. Cancer. 2002. PMID: 12404294 Review.
Cited by
-
Caloric restriction mitigates age-associated senescence characteristics in subcutaneous adipose tissue-derived stem cells.Aging (Albany NY). 2024 May 9;16(9):7535-7552. doi: 10.18632/aging.205812. Epub 2024 May 9. Aging (Albany NY). 2024. PMID: 38728252 Free PMC article.
References
-
- Ren J-X, Gong Y, Ling H, Hu X, Shao Z-M. Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics. Breast Cancer Res. Treat. 2019;173:225–237. doi: 10.1007/s10549-018-4956-y. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources